HB Wealth Management LLC Decreases Stake in HCA Healthcare, Inc. (NYSE:HCA)

HB Wealth Management LLC cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 13.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,930 shares of the company’s stock after selling 624 shares during the quarter. HB Wealth Management LLC’s holdings in HCA Healthcare were worth $1,180,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. American Century Companies Inc. grew its holdings in shares of HCA Healthcare by 60.0% in the 2nd quarter. American Century Companies Inc. now owns 23,024 shares of the company’s stock worth $7,397,000 after acquiring an additional 8,633 shares during the period. Renaissance Technologies LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter worth $4,112,000. Blair William & Co. IL increased its holdings in HCA Healthcare by 11.8% during the 2nd quarter. Blair William & Co. IL now owns 9,464 shares of the company’s stock valued at $3,041,000 after acquiring an additional 998 shares in the last quarter. Seven Eight Capital LP purchased a new stake in shares of HCA Healthcare in the second quarter valued at about $397,000. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of analyst reports. Barclays cut their price target on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a report on Friday, November 8th. Truist Financial decreased their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price target for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Finally, Oppenheimer increased their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $385.27.

Insider Buying and Selling at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is owned by insiders.

HCA Healthcare Stock Up 0.4 %

NYSE HCA opened at $310.60 on Tuesday. The business has a 50 day moving average price of $316.69 and a two-hundred day moving average price of $353.19. The stock has a market cap of $78.68 billion, a PE ratio of 13.95, a P/E/G ratio of 1.03 and a beta of 1.64. HCA Healthcare, Inc. has a fifty-two week low of $278.50 and a fifty-two week high of $417.14. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Friday, December 13th were given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.85%. The ex-dividend date of this dividend was Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.